Atlas Trials

Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)

Clinical trial NCT01569464 · COMPLETED

Trial details

NCT number
NCT01569464
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Restless Legs Syndrome
Start date
2012-03-01
Primary completion
2013-04-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.